Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab

A 65‐year‐old man with chronic progressive pulmonary aspergillosis (CPPA) was admitted for the treatment of lung adenocarcinoma while receiving an immune checkpoint inhibitor, nivolumab. The tumour responded well to the therapy, but the cavity of CPPA became large in contrast to the tumour after 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Naohiro, Fujita, Kohei, Nakatani, Koichi, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756713/
https://www.ncbi.nlm.nih.gov/pubmed/29321933
http://dx.doi.org/10.1002/rcr2.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756713/
https://www.ncbi.nlm.nih.gov/pubmed/29321933
http://dx.doi.org/10.1002/rcr2.289

Ejemplares similares